'Embedding Sustainability at Novo Nordisk: The Compassion Vs Competitiveness Dilemma
| Case Code: BECG129 Case Length: 20 Pages Period: 2005- 2012 Pub Date: 2013 Teaching Note: Available |
Price: Rs.500 Organization: Novo Nordisk Industry: Pharmaceuticals Countries: Europe; Global Themes: Corporate Social Responsibility, Sustainability, Global Competitiveness |
Abstract Case Intro 1 Case Intro 2 Excerpts
Abstract
This case is about Novo Nordisk, one of the leading global healthcare companies. The case focuses on the various steps it took to evolve as a company with sustainable development as its key focus. Over the years, it introduced several sustainability related initiatives like the Novo Nordisk Way of Management and the Triple Bottom Line philosophy.
A new sustainability strategy was developed for Novo Nordisk in the year 2000 which put global health at the center of its sustainability initiatives. These initiatives led to the integration of sustainable development with the company’s business strategy. Novo Nordisk started selling some of its insulin products at a subsidized price in some of the poorest countries in the world.
Issues
The case is structured to achieve the following teaching objectives:
- Understand the main issues related to corporate social responsibility and sustainability and the various challenges faced by organizations regarding the impact of their operations on the society and environment.
- Appreciate the importance of integrating sustainable development practices of a firm with its business strategy.
- Understand one of the key leadership challenges posed to organizations operating in emerging markets - corruption.
- Understand a key contemporary issue facing healthcare companies – the compassion vs competitiveness dilemma.
- Explore ways in which Novo Nordisk can strike the right balance between its business and global health.
Contents
-
Introduction
Background Note
History of Sustainability at Novo Nordisk
Novo Nordisk Way of Management
Triple Bottom Line
Progress on Sustainability
Climate Change
Greek Price Cut Controversy
Looking Ahead
Exhibits
Keywords
healthcare companies,Novo Nordisk,Novozymes,Triple Bottom Line philosophy,Greek Price Cut Controversy,Novo Nordisk Learning Curve,CO2 Emissions,Dow Jones Sustainability Indices,Corporate Social Responsibility; Sustainable development; Corporate Sustainability; Integrating sustainable development to business strategy; Striking the right balance between business and global health; Striking the right balance between compassion and competitiveness; Managing stakeholders; Business Ethics; Triple bottomline; Shared value; ‘Novo Nordisk Way of Management’ (NNWM); Balance scorecard; Stakeholders map
Buy this case study (Please select any one of the payment options)
| Price: Rs.500 |
Price: Rs.500 | PayPal (11 USD) |
